FYERS
Home
/
Stocks
/
Results
/
SMS Pharmaceuticals Results

SMS Pharmaceuticals Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
4%10%19%13%
10%10%-31%
15%23%52%55%
12%10%12%12%

Peer Comparison

Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
LAURUSLABS
CIPLA
DRREDDY
MANKIND
AUROPHARMA
LUPIN
SMSPHARMA
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,746.4₹424466 Cr35.0912.0762.82₹11479 Cr
9,023₹246222 Cr84.1834.04128.41₹2568 Cr
4,580₹176301 Cr80.8316.7297.06₹2163 Cr
1,124.7₹112818 Cr259.4262.53₹5040 Cr
2,036.9₹110823 Cr101.366.829.25₹889 Cr
1,314.6₹107447 Cr31.889.7757.87₹3879 Cr
1,216₹103471 Cr32.115.3263.99₹4196 Cr
2,335₹97850 Cr47.913.7571.08₹1913 Cr
1,662.9₹96836 Cr26.0817.9596.84₹3505 Cr
1,953.2₹89629 Cr16.2130.95154.35₹5333 Cr
421.8₹4100 Cr40.032.2315.22₹102 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018Mar 2008Dec 2007Sep 2007Jun 2007Mar 2007
₹207 Cr₹238 Cr₹210 Cr₹242 Cr₹196 Cr₹248 Cr₹173 Cr₹197 Cr₹164 Cr₹246 Cr₹161 Cr₹167 Cr₹135 Cr₹149 Cr₹149 Cr₹159 Cr₹64 Cr₹61 Cr₹121 Cr₹175 Cr₹163 Cr₹171 Cr₹149 Cr₹130 Cr₹113 Cr₹96 Cr₹80 Cr₹118 Cr₹117 Cr₹104 Cr₹101 Cr₹135 Cr₹125 Cr₹57 Cr₹47 Cr₹55 Cr₹51 Cr₹53 Cr
₹2 Cr₹3 Cr₹4 Cr₹1 Cr₹59 L₹1 Cr₹2 Cr₹1 Cr₹1 Cr₹2 Cr₹1 Cr₹81 L₹51 L₹1 Cr₹2 Cr₹61 L₹80 L₹43 L₹2 Cr₹1 Cr₹1 Cr₹1 Cr₹86 L₹92 L₹81 L₹3 Cr₹79 L₹58 L₹65 L₹75 L₹59 L₹1 Cr₹36 L₹61 L₹47 L₹1 Cr₹3 Cr₹54 L
₹209 Cr₹241 Cr₹214 Cr₹244 Cr₹197 Cr₹250 Cr₹175 Cr₹198 Cr₹166 Cr₹247 Cr₹163 Cr₹167 Cr₹136 Cr₹151 Cr₹151 Cr₹160 Cr₹65 Cr₹61 Cr₹123 Cr₹176 Cr₹164 Cr₹173 Cr₹150 Cr₹131 Cr₹114 Cr₹100 Cr₹81 Cr₹118 Cr₹118 Cr₹104 Cr₹102 Cr₹136 Cr₹125 Cr₹58 Cr₹47 Cr₹57 Cr₹54 Cr₹53 Cr
₹176 Cr₹208 Cr₹177 Cr₹204 Cr₹166 Cr₹216 Cr₹149 Cr₹174 Cr₹139 Cr₹220 Cr₹140 Cr₹147 Cr₹117 Cr₹134 Cr₹138 Cr₹154 Cr₹73 Cr₹73 Cr₹102 Cr₹136 Cr₹127 Cr₹136 Cr₹120 Cr₹112 Cr₹97 Cr₹88 Cr₹66 Cr₹101 Cr₹99 Cr₹93 Cr₹80 Cr₹114 Cr₹106 Cr₹48 Cr₹42 Cr₹46 Cr₹41 Cr₹38 Cr
₹43 Cr₹42 Cr₹47 Cr₹50 Cr₹40 Cr₹42 Cr₹35 Cr₹33 Cr₹35 Cr₹35 Cr₹30 Cr₹29 Cr₹27 Cr₹24 Cr₹21 Cr₹14 Cr-₹80,000-₹4 Cr₹29 Cr₹48 Cr₹46 Cr₹42 Cr₹35 Cr₹25 Cr₹22 Cr₹18 Cr₹21 Cr₹23 Cr₹24 Cr₹16 Cr₹26 Cr₹27 Cr₹24 Cr₹11 Cr₹7 Cr₹12 Cr₹14 Cr₹16 Cr
₹6 Cr₹5 Cr₹6 Cr₹6 Cr₹6 Cr₹5 Cr₹4 Cr₹5 Cr₹5 Cr₹6 Cr₹6 Cr₹6 Cr₹6 Cr₹6 Cr₹6 Cr₹5 Cr₹5 Cr₹4 Cr₹5 Cr₹5 Cr₹5 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr
₹27 Cr₹27 Cr₹31 Cr₹34 Cr₹24 Cr₹29 Cr₹22 Cr₹20 Cr₹22 Cr₹22 Cr₹17 Cr₹15 Cr₹13 Cr₹11 Cr₹7 Cr₹84 L-₹13 Cr-₹16 Cr₹16 Cr₹35 Cr₹33 Cr₹34 Cr₹27 Cr₹16 Cr₹14 Cr₹9 Cr₹12 Cr₹14 Cr₹15 Cr₹8 Cr₹19 Cr₹19 Cr₹16 Cr₹9 Cr₹4 Cr₹9 Cr₹11 Cr₹13 Cr
₹20 Cr₹21 Cr₹23 Cr₹25 Cr₹19 Cr₹20 Cr₹17 Cr₹14 Cr₹16 Cr₹16 Cr₹12 Cr₹12 Cr₹9 Cr₹8 Cr₹5 Cr₹73 L-₹10 Cr₹9 Cr₹10 Cr₹25 Cr₹23 Cr₹22 Cr₹18 Cr₹11 Cr₹9 Cr₹6 Cr₹8 Cr₹10 Cr₹9 Cr₹6 Cr₹12 Cr₹13 Cr₹10 Cr₹10 Cr₹3 Cr₹6 Cr₹7 Cr₹6 Cr

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Miscellaneous Expenses not written off
Total Assets
Book Value
Adjusted Book Value
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2007
————————————
₹9 Cr₹9 Cr₹8 Cr₹8 Cr₹8 Cr₹8 Cr₹8 Cr₹8 Cr₹8 Cr₹8 Cr₹8 Cr₹10 Cr
₹0₹16 Cr₹29 Cr₹0₹0₹0₹0₹0₹0₹0₹0₹0
₹776 Cr₹615 Cr₹499 Cr₹452 Cr₹462 Cr₹402 Cr₹340 Cr₹313 Cr₹276 Cr₹246 Cr₹285 Cr₹182 Cr
₹776 Cr₹615 Cr₹499 Cr₹452 Cr₹462 Cr₹402 Cr₹340 Cr₹313 Cr₹276 Cr₹246 Cr₹285 Cr₹182 Cr
₹786 Cr₹640 Cr₹536 Cr₹461 Cr₹470 Cr₹411 Cr₹348 Cr₹322 Cr₹284 Cr₹255 Cr₹294 Cr₹192 Cr
₹170 Cr₹138 Cr₹121 Cr₹120 Cr₹148 Cr₹146 Cr₹67 Cr₹61 Cr₹70 Cr₹73 Cr₹110 Cr₹66 Cr
₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹4 Cr₹7 Cr
₹51 Cr₹48 Cr₹43 Cr₹41 Cr₹40 Cr₹54 Cr₹40 Cr₹31 Cr₹23 Cr₹16 Cr₹45 Cr₹15 Cr
₹0₹0₹0₹61 L₹2 Cr₹3 Cr₹5 Cr₹0₹0₹0₹0₹0
₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹3 Cr₹0
₹224 Cr₹189 Cr₹166 Cr₹164 Cr₹193 Cr₹206 Cr₹114 Cr₹94 Cr₹97 Cr₹91 Cr₹162 Cr₹88 Cr
————————————
₹120 Cr₹114 Cr₹151 Cr₹107 Cr₹73 Cr₹65 Cr₹44 Cr₹48 Cr₹39 Cr₹67 Cr₹84 Cr₹24 Cr
₹80 Cr₹85 Cr₹65 Cr₹53 Cr₹55 Cr₹58 Cr₹39 Cr₹23 Cr₹23 Cr₹20 Cr₹40 Cr₹33 L
₹151 Cr₹125 Cr₹114 Cr₹94 Cr₹68 Cr₹71 Cr₹61 Cr₹71 Cr₹58 Cr₹60 Cr₹73 Cr₹0
₹27 Cr₹21 Cr₹16 Cr₹1 Cr₹16 Cr₹17 Cr₹10 Cr₹14 Cr₹14 Cr₹10 Cr₹3 Cr₹25 Cr
₹378 Cr₹345 Cr₹347 Cr₹255 Cr₹211 Cr₹211 Cr₹154 Cr₹156 Cr₹134 Cr₹156 Cr₹200 Cr₹49 Cr
₹1388 Cr₹1173 Cr₹1049 Cr₹880 Cr₹875 Cr₹828 Cr₹617 Cr₹572 Cr₹515 Cr₹502 Cr₹656 Cr₹329 Cr
₹57 Cr₹57 Cr₹6 Cr₹3 Cr₹8 Cr₹7 Cr₹2 Cr₹3 Cr₹2 Cr₹0₹8 Cr₹12 Cr
₹365 Cr₹311 Cr₹280 Cr₹253 Cr₹260 Cr₹251 Cr₹152 Cr₹144 Cr₹146 Cr₹149 Cr₹204 Cr₹73 Cr
————————————
₹801 Cr₹760 Cr₹631 Cr₹576 Cr₹570 Cr₹559 Cr₹361 Cr₹340 Cr₹318 Cr₹310 Cr₹501 Cr₹96 Cr
₹267 Cr₹227 Cr₹193 Cr₹164 Cr₹132 Cr₹101 Cr₹80 Cr₹58 Cr₹39 Cr₹19 Cr₹130 Cr₹27 Cr
₹534 Cr₹533 Cr₹437 Cr₹412 Cr₹438 Cr₹457 Cr₹280 Cr₹281 Cr₹279 Cr₹290 Cr₹370 Cr₹69 Cr
₹122 Cr₹35 Cr₹30 Cr₹33 Cr₹11 Cr₹7 Cr₹42 Cr₹18 Cr₹8 Cr₹8 Cr₹13 Cr₹15 Cr
₹26 Cr₹12 Cr₹11 Cr₹11 Cr₹22 Cr₹27 Cr₹26 Cr₹27 Cr₹28 Cr₹29 Cr₹21 Cr₹0
₹26 Cr₹12 Cr₹11 Cr₹11 Cr₹22 Cr₹27 Cr₹26 Cr₹27 Cr₹28 Cr₹29 Cr₹21 Cr₹0
₹39 Cr₹16 Cr₹19 Cr₹11 Cr₹9 Cr₹9 Cr₹38 Cr₹23 Cr₹16 Cr₹7 Cr₹4 Cr₹0
₹4 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹0₹0
₹724 Cr₹598 Cr₹500 Cr₹469 Cr₹482 Cr₹503 Cr₹389 Cr₹351 Cr₹334 Cr₹336 Cr₹408 Cr₹84 Cr
————————————
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹3 L
₹351 Cr₹285 Cr₹234 Cr₹223 Cr₹251 Cr₹138 Cr₹129 Cr₹136 Cr₹107 Cr₹93 Cr₹113 Cr₹50 Cr
₹216 Cr₹203 Cr₹236 Cr₹148 Cr₹49 Cr₹106 Cr₹49 Cr₹26 Cr₹24 Cr₹21 Cr₹61 Cr₹60 Cr
₹46 Cr₹42 Cr₹36 Cr₹7 Cr₹47 Cr₹41 Cr₹10 Cr₹15 Cr₹13 Cr₹12 Cr₹15 Cr₹96 Cr
₹7 Cr₹8 Cr₹7 Cr₹6 Cr₹6 Cr₹3 Cr₹4 Cr₹2 Cr₹2 Cr₹1 Cr₹2 Cr₹2 Cr
₹43 Cr₹37 Cr₹36 Cr₹25 Cr₹39 Cr₹39 Cr₹36 Cr₹41 Cr₹35 Cr₹39 Cr₹57 Cr₹27 Cr
₹663 Cr₹575 Cr₹549 Cr₹411 Cr₹392 Cr₹325 Cr₹228 Cr₹221 Cr₹181 Cr₹166 Cr₹248 Cr₹234 Cr
₹285 Cr₹230 Cr₹202 Cr₹156 Cr₹181 Cr₹114 Cr₹74 Cr₹65 Cr₹47 Cr₹10 Cr₹47 Cr₹185 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹12 Cr
₹1388 Cr₹1173 Cr₹1049 Cr₹880 Cr₹875 Cr₹828 Cr₹617 Cr₹572 Cr₹515 Cr₹502 Cr₹656 Cr₹329 Cr
₹84₹70₹60₹54₹56₹48₹41₹38₹34₹30₹35₹180
₹84₹70₹60₹54₹56₹48₹41₹38₹34₹30₹35₹18

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Cash & Cash Equivalent on Amalgamation / Take over / Merger
Closing Cash & Cash Equivalent
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2007
₹117 Cr₹92 Cr₹66 Cr₹5 Cr₹68 Cr₹91 Cr₹51 Cr₹62 Cr₹60 Cr₹42 Cr₹56 Cr₹40 Cr
₹61 Cr₹52 Cr₹54 Cr₹53 Cr₹50 Cr₹28 Cr₹29 Cr₹27 Cr₹31 Cr₹32 Cr₹28 Cr₹18 Cr
-₹94 Cr-₹43 Cr-₹55 Cr-₹31 Cr-₹58 Cr-₹12 Cr-₹28 Cr-₹26 Cr-₹48 Cr₹9 Cr-₹1 Cr-₹30 Cr
₹83 Cr₹102 Cr₹66 Cr₹27 Cr₹60 Cr₹107 Cr₹52 Cr₹63 Cr₹43 Cr₹83 Cr₹83 Cr₹28 Cr
₹59 Cr₹82 Cr₹50 Cr₹22 Cr₹45 Cr₹90 Cr₹40 Cr₹50 Cr₹32 Cr₹73 Cr₹61 Cr₹14 Cr
-₹131 Cr-₹123 Cr-₹52 Cr-₹30 Cr-₹27 Cr-₹152 Cr-₹43 Cr-₹35 Cr-₹17 Cr-₹39 Cr-₹97 Cr-₹32 Cr
₹76 Cr₹47 Cr₹31 Cr-₹32 Cr-₹12 Cr₹92 Cr-₹2 Cr-₹13 Cr-₹15 Cr-₹33 Cr₹44 Cr₹107 Cr
₹4 Cr₹5 Cr₹29 Cr-₹39 Cr₹6 Cr₹31 Cr-₹5 Cr₹2 Cr₹35 L₹1 Cr₹9 Cr₹89 Cr
₹41 Cr₹36 Cr₹7 Cr₹47 Cr₹40 Cr₹10 Cr₹15 Cr₹13 Cr₹12 Cr₹11 Cr₹2 Cr₹7 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹0-₹29 L₹0₹0
₹46 Cr₹41 Cr₹36 Cr₹7 Cr₹47 Cr₹40 Cr₹10 Cr₹15 Cr₹13 Cr₹12 Cr₹11 Cr₹96 Cr

Fundamental Ratios

Consolidated
Standalone
Empty box

No results found

Share Price Live Stats

Open (₹)438.30
Volume (₹)2.60 L
High (₹)441.60
Upper Circuit525.95
Low (₹)421.60
Lower Circuit350.65
Prev Close438.30
52W High (₹)494.45
Price421.80
52W Low (₹)270.10

Share Market Cap & Key Ratios Overview

M.Cap (₹)4099.62 Cr
Div. Yield (%)0.09
PE Ratio40.03
Debt to Equity0.46
Price to Book4.47
Book Value83.91
EPS (TTM)10.93
Face Value1.00
ROE (%)12.49

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
LAURUSLABSNSE
CIPLANSE
DRREDDYNSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
SMSPHARMANSE
LTP
1W Low
1W High
Market cap (₹)
1746.4-13.6 (-0.77%)
1725.50
1776.60
4,24,466Cr
9023-317 (-3.39%)
8937.50
9431.50
2,46,222Cr
4580-76.9 (-1.65%)
4551.80
4682
1,76,301Cr
1124.7+7.2 (0.64%)
1107.30
1150.90
1,12,818Cr
2036.9+0.3 (0.01%)
2007.80
2069.20
1,10,823Cr
1314.6+13.6 (1.05%)
1300.20
1333.30
1,07,447Cr
1216+19 (1.59%)
1196.90
1250.70
1,03,471Cr
2335-33.5 (-1.41%)
2317.50
2426.80
97,850Cr
1662.9-30.1 (-1.78%)
1654.10
1715
96,836Cr
1953.2-3.3 (-0.17%)
1925.70
1964.90
89,629Cr
421.8-22.85 (-5.14%)
421.60
454.90
4,100Cr

SMS Pharmaceuticals Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹42.7Cr; with other income of ₹1.74Cr, profit before interest and tax came to ₹32.7Cr. Interest expense was ₹5.5Cr; PBT before exceptional items stood at ₹27.2Cr. Cost mix (full year): raw materials ₹501.87Cr; employee cost ₹69.72Cr; depreciation ₹9.99Cr; other expenses ₹166.01Cr. Basis: consolidated annual results.

SMS Pharmaceuticals Ltd Quaterly Results Key Takeaways

SMS Pharmaceuticals Ltd reported ₹206.97Cr total income from operations in Jun 2026, softer than ₹237.95Cr in Mar 2026 but higher than ₹196.05Cr in Jun 2025. Operating profit (before other income, interest and exceptional items) was ₹42.7Cr; with other income of ₹1.74Cr, profit before interest and tax came to ₹32.7Cr. Interest expense was ₹5.5Cr, taking profit before tax to ₹27.2Cr. After tax of ₹7Cr, profit after tax stood at ₹20.2Cr (vs ₹20.96Cr in Mar 2026 and ₹18.71Cr in Jun 2025).